Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-019040)

Filing Details

Accession Number:: 0001209191-20-019040
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-13 18:56:58
Reporting Period:: 2020-03-13

Accepted Time:: 2020-03-13 18:56:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124105	Catalyst Biosciences Inc.	CBIO	Pharmaceutical Preparations (2834)	562020050

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1206872	Nassim Usman	611 Gateway Boulevard, Suite 710 South San Francisco CA 94080	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-13	4,000	$3.91	11,010	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,456	Indirect	By The Usman Family Trust
Common Stock	1,168	Indirect	By Nassim Usman IRA

Footnotes

Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $3.87 to $3.92 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.